Corcept Therapeutics | Attività Correnti



Current Assets Cambiamento Data
Acadia Pharmaceuticals USD 870.94M 67.38M 2025-03
Alaunos Therapeutics USD 2.76M 795K 2024-12
ANI Pharmaceuticals USD 536.29M 8.61M 2025-03
Ardelyx USD 356.45M 72.35M 2024-12
Aurora Cannabis CAD 494.21M 76.54M 2024-12
BioMarin Pharmaceutical USD 3.47B 235.48M 2025-03
Bristol-Myers Squibb USD 30.78B 1B 2025-03
Canopy Growth CAD 341.08M 50.58M 2024-12
Corcept Therapeutics USD 438.5M 33.1M 2025-03
Eli Lilly USD 41.26B 8.52B 2025-03
J&J USD 71.55B 15.66B 2025-03
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Merck USD 35.5B 3.28B 2025-03
Novartis USD 29.7B 1.56B 2024-12
Novartis USD 29.7B 1.56B 2024-12
Pacira USD 759.96M 14.83M 2025-03
Pfizer USD 45.86B 4.5B 2025-03
Supernus Pharmaceuticals USD 686.07M 46.07M 2024-12
TG Therapeutics USD 566.36M 7.71M 2024-12



Corcept Therapeutics Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.